نمایش پرونده ساده آیتم

dc.contributor.authorArdeshirylajimi, A
dc.contributor.authorFarshdousti Hagh, M
dc.contributor.authorSaki, N
dc.contributor.authorMortaz, E
dc.contributor.authorSoleimani, M
dc.contributor.authorRahim, F
dc.date.accessioned2018-08-26T08:55:26Z
dc.date.available2018-08-26T08:55:26Z
dc.date.issued2013
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54300
dc.description.abstractMultiple Sclerosis is an inflammatory disease of the central nervous system in which T cells experienced a second phase of activation, which ultimately leads to axonal demyelination and neurological disability. Recent advancements in stem cell therapies may serve as potential treatments for neurological disorders. There are broad types of stem cells such as neural, embryonic, mesenchymal and hematopoietic stem cells with unprecedented hope in treating many debilitating diseases. In this paper we will review the substantial literature regarding experimental and clinical use of these stem cells and possible mechanisms in the treatment of MS. These results may pave the road for the utilization of stem cells for the treatment of MS.
dc.language.isoEnglish
dc.relation.ispartofInternational Journal of Hematology-Oncology and Stem Cell Research
dc.subjectdemyelination
dc.subjectembryonic stem cell
dc.subjecthematopoietic stem cell
dc.subjecthuman
dc.subjectlymphocyte activation
dc.subjectmesenchymal stem cell
dc.subjectmultiple sclerosis
dc.subjectnerve fiber
dc.subjectneural stem cell
dc.subjectneurologic disease
dc.subjectreview
dc.subjectstem cell transplantation
dc.subjectsystematic review
dc.subjectT lymphocyte
dc.titleFeasibility of cell therapy in multiple sclerosis: A systematic review of 83 studies
dc.typeArticle
dc.citation.volume7
dc.citation.issue1
dc.citation.spage13
dc.citation.epage30
dc.citation.indexScopus


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم